Effect of 6-hydroxydopamine treatment in the area postrema on morphine-induced emesis in ferrets

Japanese Journal of Pharmacology

Volumn 89, Issue 4, 2002, Pages 422-425

  Yoshikawa, Takashi ^a   Yoshida, Naoyuki ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

6 Hydroxydopamine; Emesis; Morphine

Indexed keywords

CATECHOLAMINE; DOPAMINE; HOMOVANILLIC ACID; MORPHINE; OXIDOPAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA POSTREMA; ARTICLE; CATECHOLAMINE RELEASE; DOPAMINE RELEASE; DRUG EFFECT; DRUG RESPONSE; FERRET; MALE; MEDULLA OBLONGATA; NONHUMAN; STATISTICAL SIGNIFICANCE; VOMITING;

EID: 0036670495     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.89.422     Document Type: Article

References (15)

1. Clinical effects of parenteral narcotics in hospitalized medical patients
2. Animal models in the study of vomiting
3. Pharmacological agents affecting emesis. A review (Part I)
4. The role of tachykinin NK-1 receptors in the area postrema of ferrets in emesis
5. The actions of fentanyl to inhibit drug-induced emesis
6. Stimulant effects of enkephalin microinjection into the dopaminergic A10 area
7. Morphine and delta-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus
8. Evidence for the existence of L-dopa- and dopamine-immunoreactive nerve cell bodies in the caudal part of the dorsal motor nucleus of the vagus nerve
9. Locus of emetic action of morphine and hydergine in dogs
10. Naloxone antagonizes narcotic self blockade of emesis in the cat
11. The role of norepinephrine in the function of the area postrema. I. Immunofluorescent localization of dopamine-beta-hydroxylase and electron microscopy
12. Immunocytochemical localization of catecholamine synthesizing enzymes and neuropeptides in area postrema and medial nucleus tractus solitarius of rat brain
13. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine
14. Alpha adrenoceptor subtypes involved in the emetic action in dogs
15. The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist